Treatments & Interventions
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Anorexia
Very frequent (80-99%)HP:0002039
Dehydration
Very frequent (80-99%)HP:0001944
Diabetes insipidus
Very frequent (80-99%)HP:0000873
Extreme thirst
Very frequent (80-99%)HP:0001959
Nocturia
Very frequent (80-99%)HP:0000017
Postnatal failure to thrive
Very frequent (80-99%)HP:0001508
Weight loss
Very frequent (80-99%)HP:0001824
Anxiety disease
Frequent (30-79%)HP:0000739
Depression
Frequent (30-79%)HP:0000716
Excessive daytime somnolence
Frequent (30-79%)HP:0001262
Headache
Frequent (30-79%)HP:0002315
Pyrexia
Frequent (30-79%)HP:0001945
Torpor
Frequent (30-79%)HP:0001254
Diarrhea
Occasional (5-29%)HP:0002014
Hyponatremia
Occasional (5-29%)HP:0002902
Nausea and vomiting
Occasional (5-29%)HP:0002017
Seizures
Occasional (5-29%)HP:0001250
Decreased circulating osteocalcin level
HP:0031429
Excess astrocytes in brain
HP:0002171
Increased distance between eyes
HP:0000316
Increased length of philtrum
HP:0000343
Increased nasal width
HP:0000445
Neurohypophyseal diabetes insipidus
HP:0000863
Osteopenia
HP:0000938
Small nose
HP:0003196
Related Conditions
Familial central diabetes insipidus(child)
Post-traumatic central diabetes insipidus(child)
Secondary vasopressin deficiency(child)
X-linked intellectual disability, limb spasticity, retinal dystrophy, diabetes insipidus syndrome(child)
Vasopressin-related polyuria(parent)
Disorder of posterior pituitary(parent)
Quick Facts
- SNOMED CT
- 45369008
- UMLS CUI
- C0687720
- Fully Specified Name
- Arginine vasopressin deficiency (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 25
- Known Treatments
- 2
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.